© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Business Strategy
Trusted Networks Key to Moving Forward
July 19, 2022
Sharing technologies like blockchain could help healthcare institutions establish a consistent, accurate, and trustworthy approach to data collection and dissemination.
Specialty Pharmacy Has Won Lawsuit Against CVS Caremark
July 06, 2022
The case concerns the controversial direct and indirect remuneration (DIR) fees that pharmacy benefit managers (PBMs) collect from pharmacies. Meanwhile, a separate whistleblower lawsuit has been filed against CVS Caremark, its parent company and SilverScripts, its Part D plan, accusing them of blocking customers from getting cheaper generic drugs.
Hospitals see lower readmissions with more post-discharge options
July 05, 2022
Health systems with more primary care doctors and palliative care services saw fewer people coming back to the hospital, a new study finds.
Medicaid Directors Prepare for the End of the Public Health Emergency
June 20, 2022
As many asme 14 million people with Medicaid coverage stand to lose their health insurance when the COVID-19 public health emergency ends.
Digital Therapeutics Emerge Into Uncertain Regulatory, Payment Landscape
June 16, 2022
Legislation that would establish benefit categories for digital therapeutics has been introduced in Congress.
Managing and Retaining Employees During Periods of Disruptive Change
June 07, 2022
To thrive organizations must figure out how to build and maintain a strong culture in an increasingly remote workplace, and implement effective recruitment and retention strategies in an economy where there are fewer workers.
Researchers Identify a Communications Breakdown Over Herceptin Biosimilars
June 06, 2022
If biosimilar acceptance is to grow, it’s going to take a great deal of work to improve the levels of trust between payers, patients, and oncologists.
Review Paper Argues for Broader Use of Riabni, a Rituxan Biosimilar
June 03, 2022
The review, partly funded by Amgen, the maker of Riabni, makes the case for using the biosimilar to Rituxan for all indications of the originator.
New Digital Therapeutics Guide Aims to Bring High Standards, Clarity
June 01, 2022
The guide is designed to help spread best practices and help healthcare decision-makers understand the benefits of digital therapeutics.